Literature DB >> 11826364

Deletion of the NF2 region in both meningioma and juxtaposed meningioangiomatosis: case report supporting a neoplastic relationship.

P Sinkre1, A Perry, D Cai, R Raghavan, M Watson, K Wilson, B Barton Rogers.   

Abstract

We report a case of juxtaposed atypical meningioma and meningioangiomatosis (MA) in an 8-year-old boy with no clinical stigmata or family history of neurofibromatosis. We studied the proliferative activity and genetic changes in the two lesions in an attempt to define their biologic and pathogenetic relationships. The MIB-1 index was 11% in the meningioma and <1% in the MA, indicating increased proliferative activity in the meningioma. Fluorescence in situ hybridization was done for two chromosomal regions commonly deleted in meningiomas. There was loss of the neurofibromatosis 2 locus (22q12) in both the meningioma and MA. Conversely, the region of 1p32 was not deleted. Our results indicate that both the meningioma and MA arose from the same clonal process, with the meningioma probably undergoing additional, but undefined, genetic alterations that confer upon it a more proliferative potential. This loss of 22q12 in the MA raises doubt about the presumed hamartomatous nature of MA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11826364     DOI: 10.1007/s10024001-0086-2

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  12 in total

Review 1.  Pediatric meningioma: current approaches and future direction.

Authors:  Rishi S Kotecha; Reimar C Junckerstorff; Sharon Lee; Catherine H Cole; Nicholas G Gottardo
Journal:  J Neurooncol       Date:  2011-01-04       Impact factor: 4.130

Review 2.  Sporadic meningioangiomatosis-associated atypical meningioma mimicking parenchymal invasion of brain: a case report and review of the literature.

Authors:  Yan-Yang Chen; Xiao-Ying Tiang; Zhi Li; Bo-Ning Luo; Quan Huang
Journal:  Diagn Pathol       Date:  2010-06-18       Impact factor: 2.644

3.  Sporadic meningioangiomatosis: imaging findings with histopathologic correlations in seven patients.

Authors:  Tae Yeon Jeon; Ji Hye Kim; Yeon-Lim Suh; Soomin Ahn; So-Young Yoo; Hong Eo
Journal:  Neuroradiology       Date:  2013-10-24       Impact factor: 2.804

Review 4.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

5.  Meningioangiomatosis with meningioma: an uncommon association of a rare entity--report of a case and review of the literature.

Authors:  Prabal Deb; Aditya Gupta; Mehar Chand Sharma; Shailesh Gaikwad; V P Singh; Chitra Sarkar
Journal:  Childs Nerv Syst       Date:  2005-01-26       Impact factor: 1.475

6.  A case of infantile meningioangiomatosis with a separate cyst.

Authors:  Seong Ho Kim; Soo Han Yoon; Jang Hee Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-09-30

7.  Allelic loss on chromosomes 1p32, 9p21, 13q14, 16q22, 17p, and 22q12 in meningiomas associated with meningioangiomatosis and pure meningioangiomatosis.

Authors:  Na Rae Kim; Seong Jin Cho; Yeon-Lim Suh
Journal:  J Neurooncol       Date:  2009-04-05       Impact factor: 4.130

8.  Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.

Authors:  Craig W Menges; Eleonora Sementino; Jacqueline Talarchek; Jinfei Xu; Jonathan Chernoff; Jeffrey R Peterson; Joseph R Testa
Journal:  Mol Cancer Res       Date:  2012-07-12       Impact factor: 5.852

9.  Molecular Alterations in Meningioangiomatosis Causing Epilepsy.

Authors:  Antonio Dono; Azim Z Pothiawala; Cole T Lewis; Meenakshi B Bhattacharjee; Leomar Y Ballester; Nitin Tandon
Journal:  J Neuropathol Exp Neurol       Date:  2021-09-27       Impact factor: 3.685

10.  Meningioangiomatosis: a case report and literature review emphasizing diverse appearance on different imaging modalities.

Authors:  Osama N Kashlan; David V Laborde; Lakesha Davison; Amit M Saindane; Daniel Brat; Patricia A Hudgins; Robert E Gross
Journal:  Case Rep Neurol Med       Date:  2011-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.